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A case of Vogt-Koyanagi-Harada disease (VKH) that developed in a 36-year-old woman with Graves’ disease 
was described. The patient was treated with Lugol’s solution and presented with bilateral serous retinal 
detachment. She had also suffered from methimazole-induced hypersensitivity and steroid-induced myopathy. 
Fluorescein angiography showed multiple leakage points and a lumbar puncture revealed pleocytosis, which was 
compatible with VKH. High dose steroid pulse therapy was successful. Altered immune regulation associated with 
drug-induced hypersensitivity may contribute to the development of VKH in patients with Graves’ disease.
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Fig. 1. Fundus photography, fluorescein angiography (FAG) and 
optical coherence tomography (OCT) performed at the initial visit. 
At that time, predisolone dosage was 10 mg. (A and B) Fundus pho-
tography of both eyes. (C and D) FAG showed multiple leakage 
points. (E and F) OCT showed subretinal fluid affecting macula.
Vogt-Koyanagi-Harada disease (VKH) is a systemic auto-
immune disorder affecting pigmented tissues in the ocular, 
auditory, integumentary and central nervous systems.
1 Graves’ 
disease is an immune disorder, most commonly caused by 
hyperthyroidism. Previously, a case of VKH that developed 
in a patient with Hashimoto’s thyroiditis was reported.
2 How-
ever, the explanation for the association of hyperthyroidism 
and VKH remains unclear. Here, we describe a case of VKH 
that developed in a patient with Graves’ disease.
Case Report
A 36-year-old woman was referred for blurred vision in 
both eyes that had lasted for three days. She complained of a 
stiff neck and headache occurring over the same period. She 
had been diagnosed with Graves’ disease one year previously 
and was treated with methimazole. However, she had dis-
continued the methimazole seven months prior, because she 
was diagnosed with methimazole-induced hypersensitivity 
following development of a skin rash. After discontinuing the 
methimazole, the patient was treated with Lugol’s solution 
with 30 mg of prednisolone. After three months, she complained 
of lower limb weakness. A muscle biopsy was performed, 
revealing prednisolone-induced myopathy. The dose of pred-
nisolone was reduced to 10 mg. After symptoms developed, 
she was taken to the hospital for evaluation of systemic diseases 
in the allergy division of the Department of Internal Medicine. 
She was referred to retinal clinic for ocular examination.
On examination, her best-corrected visual acuities (BCVA) 
were 20/100 in both eyes. The anterior chamber was within 
normal limits. A fundus examination showed disc edema 
accompanied by a serous retinal detachment in both eyes 
(Fig. 1 A and B). Fluorescein angiography (FAG) showed JH Seo, et al. VKH WITH GRAVES DISEASE
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Fig. 2. Fluorescein angiography (FAG) and indocyanine green an-
giography (ICG) performed after 1 week of close observation using 
5 mg predisolone under the impression of steroid induced central se-
rous retinopathy. Anterior chamber reaction with vitritis developed. 
(A and B) FAG showed multiple pin point size leakages. (C and D) 
ICG showed multiple hypofluorescent spots.
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Fig. 3. Fundus photography, fluorescein angiography (FAG) and 
optical coherence tomography (OCT) performed 4 weeks later. 
After high-dose steroid (500 mg methylpredisolone) pulse therapy, 
the patient was given 30 mg predisolone with 75 mg of cyclo-
sporine. (A and B) Fundus photography of both eyes. (C and D) 
FAG showed the multiple leakages point had disappeared. (E and 
F) OCT showed that subretinal fluid.
multiple leaks at the posterior pole (Fig. 1 C and D). In addition, 
optical coherence tomography (OCT) revealed subretinal fluid 
(Fig. 1 E and F). Initially, we suspected prednisolone-induced 
central serous chorioretinopathy. We decided to observe the 
patient closely with predisolone tapering to 5 mg for 1 week.
After seven days, the patient’s visual acuity did not change, 
but the subretinal fluid buildup and the retinal detachment 
worsened. Simultaneously, anterior chamber reaction and 
vitreous haze developed in both eyes. The leakage pattern on 
FAG changed (Fig. 2 A and B), and indocyanine green angio-
graphy revealed multiple hypofluorescent spots (Fig. 2 C and 
D). A lumbar puncture revealed pleocytosis with 21 mono-
nuclear cells/dL. The patient was diagnosed with VKH disease 
and treatment with high dose steroid pulse therapy was 
recommended. Although the internal medicine physicians 
were reluctant to use steroids due to the patient’s steroid- 
induced myopathy, intravenous administration of 500 mg of 
methylprednisolone for three days followed by 30 mg pred-
nisolone with 75 mg of cyclosporine per day was provided. 
After 40 days, her BCVA recovered to 20/40 OD, 20/25 OS. 
Fundus examination showed attached retinas bilaterally, and 
FAG revealed that the leaks had resolved in both eyes (Fig. 3).
Discussion
Since both VKH and Graves’ disease are caused by T 
cell-mediated autoimmune dysfunction, they might share a 
common pathogenic process.
3,4 Moreover, in this case, altered 
immune regulation that may have resulted from drug-induced 
hypersensitivity may have contributed to the development of 
VKH. Although our patient received 10 mg of prednisolone, 
this did not prevent the development of VKH. This case study 
illustrates the diagnostic and therapeutic challenges of VKH- 
associated autoimmune diseases.
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